InflaRx NV (FRA:IF0) E10: €-1.06 (As of Mar. 2026)


FRA:IF0 InflaRx NV FRA:IF0
28 GF Score
Price €1.54
! 5 Warning Signs
View Full Analysis

What is InflaRx NV E10?

InflaRx NV FRA:IF0 -6.95% 28 E10 is €-1.06 as of Mar. 2026. GuruFocus rates FRA:IF0 with a GF Score™ of 28/100. The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

InflaRx NV's adjusted earnings per share data for the three months ended in Mar. 2026 was €-0.080. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-1.06 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-06-27), InflaRx NV's current stock price is €1.54. InflaRx NV's E10 for the quarter that ended in Mar. 2026 was €-1.06. InflaRx NV's Shiller PE Ratio of today is .


InflaRx NV  (FRA:IF0) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


InflaRx NV E10 Related Terms


InflaRx NV E10 Historical Data

* Premium members only.

The historical data trend for InflaRx NV's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InflaRx NV E10 Chart

InflaRx NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -1.19

InflaRx NV Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -1.19 -1.06

FRA:IF0 vs IRD, NAUT, RGNX: E10 Comparison

For the Biotechnology subindustry, InflaRx NV's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InflaRx NV Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, InflaRx NV's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where InflaRx NV's Shiller PE Ratio falls into.


FRA:IF0
28GF Score
InflaRx NV FRA:IF0
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

InflaRx NV E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, InflaRx NV's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.08/131.2583*131.2583
=-0.080

Current CPI (Mar. 2026) = 131.2583.

InflaRx NV Quarterly Data

per share eps CPI Adj_EPS
201606 -0.046 100.717 -0.060
201609 -0.092 101.017 -0.120
201612 -0.186 101.217 -0.241
201703 -0.162 101.417 -0.210
201706 -0.200 102.117 -0.257
201709 -0.173 102.717 -0.221
201712 -0.492 102.617 -0.629
201803 -0.430 102.917 -0.548
201806 -0.100 104.017 -0.126
201809 -0.260 104.718 -0.326
201812 -0.400 104.217 -0.504
201903 -0.380 104.217 -0.479
201906 -0.590 105.718 -0.733
201909 -0.560 106.018 -0.693
201912 -0.520 105.818 -0.645
202003 -0.320 105.718 -0.397
202006 -0.380 106.618 -0.468
202009 -0.250 105.818 -0.310
202012 -0.320 105.518 -0.398
202103 -0.180 107.518 -0.220
202106 -0.330 108.486 -0.399
202109 -0.270 109.435 -0.324
202112 -0.290 110.384 -0.345
202203 -0.320 113.968 -0.369
202206 0.010 115.760 0.011
202209 -0.180 118.818 -0.199
202212 -0.180 119.345 -0.198
202303 -0.250 122.402 -0.268
202306 -0.140 123.140 -0.149
202309 -0.130 124.195 -0.137
202312 -0.280 123.773 -0.297
202403 -0.170 125.038 -0.178
202406 -0.240 125.882 -0.250
202409 -0.300 126.198 -0.312
202412 -0.080 127.041 -0.083
202503 -0.130 127.779 -0.134
202506 -0.210 128.412 -0.215
202509 -0.180 129.255 -0.183
202512 -0.150 129.361 -0.152
202603 -0.080 131.258 -0.080

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €-1.06 mean?
InflaRx NV (FRA:IF0) has a E10 of €-1.06 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on InflaRx NV and its competitors.
Is InflaRx NV's E10 too high?
InflaRx NV's current E10 is €-1.06. Overall, InflaRx NV has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does InflaRx NV's E10 compare to IRD and NAUT?
InflaRx NV's E10 of €-1.06 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on InflaRx NV and its competitors. InflaRx NV's current E10 is €-1.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InflaRx NV stock overvalued right now?
InflaRx NV (FRA:IF0) has a current E10 of €-1.06. The current E10 is €-1.06. InflaRx NV's overall GF Score™ is 28/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For InflaRx NV (FRA:IF0), the current E10 is €-1.06 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

InflaRx NV Business Description

Other Exchanges IFRX:USA
Address Winzerlaer Strasse 2, Jena, DEU, 07745
InflaRx NV is a biopharmaceutical company applying proprietary technologies to discover, develop and commercialize potent and specific inhibitors of the complement activation factor known as C5a and its receptor C5aR. With its therapeutic product candidates, vilobelimab and izicopan, the company targets C5a and its receptor C5aR to selectively inhibit the powerful inflammatory response observed in a wide variety of autoimmune and other inflammatory diseases elicited through C5a/C5aR activation. Its product candidate, GOHIBIC (vilobelimab), is a novel intravenously delivered anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
28GF Score

Get the complete analysis for FRA:IF0

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.54
Price